S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
TSE:WEED

Canopy Growth Stock Forecast, Price & News

C$9.16
-0.30 (-3.17%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
C$9.01
C$9.46
50-Day Range
C$9.16
C$18.11
52-Week Range
C$9.01
C$71.60
Volume
2.66 million shs
Average Volume
2.47 million shs
Market Capitalization
C$3.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive WEED News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.


Canopy Growth logo

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Cannabis
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2,700
Year Founded
N/A

Sales & Book Value

Annual Sales
C$568.55 million
Cash Flow
C$4.43 per share
Book Value
C$10.78 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
C$3.61 billion
Optionable
Not Optionable

Company Calendar

Today
1/21/2022
Next Earnings (Estimated)
2/09/2022

MarketRank

Overall MarketRank

2.04 out of 5 stars

Analyst Opinion: 3.9Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -












Canopy Growth (TSE:WEED) Frequently Asked Questions

Is Canopy Growth a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are currently 6 sell ratings, 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WEED, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth
or view top-rated stocks.

How has Canopy Growth's stock price been impacted by Coronavirus (COVID-19)?

Canopy Growth's stock was trading at C$18.33 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, WEED stock has decreased by 50.0% and is now trading at C$9.16.
View which stocks have been most impacted by COVID-19
.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Canopy Growth
.

What price target have analysts set for WEED?

14 brokers have issued 1-year price objectives for Canopy Growth's stock. Their forecasts range from C$7.00 to C$45.00. On average, they anticipate Canopy Growth's share price to reach C$19.08 in the next year. This suggests a possible upside of 108.3% from the stock's current price.
View analysts' price targets for Canopy Growth
or view top-rated stocks among Wall Street analysts.

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include (CGC), Aurora Cannabis (ACB), Aphria (APHA), Aurora Cannabis (ACB), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACBFF), GW Pharmaceuticals (GWPH) and Alibaba Group (BABA).

What is Canopy Growth's stock symbol?

Canopy Growth trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WEED."

How do I buy shares of Canopy Growth?

Shares of WEED and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of WEED stock can currently be purchased for approximately C$9.16.

How much money does Canopy Growth make?

Canopy Growth has a market capitalization of C$3.61 billion and generates C$568.55 million in revenue each year.

How many employees does Canopy Growth have?

Canopy Growth employs 2,700 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

Where are Canopy Growth's headquarters?

Canopy Growth is headquartered at 1 Hershey Dr, SMITHS FALLS, ON K7A 0A8, Canada.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 Hershey Dr, SMITHS FALLS, ON K7A 0A8, Canada. The company can be reached via phone at +1-613-5999600.


This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.